What Key Growth Drivers Are Shaping The Acute Respiratory Distress Syndrome (ARDS) Market Forecast Toward $2.15 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Acute Respiratory Distress Syndrome (ARDS) Market Be Worth By 2029?
The market size for acute respiratory distress syndrome (ards) has seen substantial growth in recent years. The anticipated increase from $1.29 billion in 2024 to $1.41 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%, indicates a strong market performance. Factors contributing to this significant growth include advances in critical care medicine, an increasing aging population, progress in pulmonary rehabilitation, and the effectiveness of multidisciplinary care teams.
The market size for acute respiratory distress syndrome (ards) is projected to experience swift expansion over the upcoming years. The market is expected to reach a value of $2.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%. This growth during the forecast period may be due to factors such as global preparedness for healthcare emergencies, advancements in vaccine production, and effective management of infectious diseases, along with the rise of telemedicine and remote patient monitoring, and development of patient-centric care models. Key trends for this period comprise artificial lung devices, individualized ventilation strategies, lung-protective ventilation techniques, and specific drug therapies for different ards types.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
What Market Forces Are Contributing To The Growth Of The Acute Respiratory Distress Syndrome (ARDS) Market?
The escalating occurrence of pneumonia is anticipated to drive the expansion of the acute respiratory distress syndrome (ARDS) market in the future. Pneumonia is an infection that can infect one or both lungs, causing the air sacs, or alveoli, within the lungs to become filled with fluid or pus. This infection prompts an inflammatory response in the lungs, causing blood vessels to become more permeable and allowing fluid to leak into the alveoli. The accumulation of this fluid disrupts the exchange of oxygen and carbon dioxide, resulting in respiratory discomfort. For example, in November 2023, the Centre for Tropical Medicine and Global Health, a prominent healthcare research entity based in the UK, reported that the number of pneumonia cases in Kenya saw a considerable surge, reaching 793,864 in 2022-2023, a significant increase from 477,186 cases in 2020-2021. Therefore, the escalating occurrence of pneumonia is fuelling the growth of the acute respiratory distress syndrome (ARDS) market.
Which Segments Define The Structure Of The Acute Respiratory Distress Syndrome (ARDS) Market?
The acute respiratory distress syndrome (ards)market covered in this report is segmented –
1) By Type: Diagnosis; Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19); Sepsis; Inhalation Of Harmful Substances; Severe Pneumonia; Other Causes
3) By Severity: Mild; Moderate; Severe
4) By End User: Hospitals; Clinics; Ambulatory Service Centers; Other End Users
Subsegments:
1) By Diagnosis: Imaging Tests; Blood Tests; Lung Function Tests; Other Diagnostic Methods
2) By Treatment: Mechanical Ventilation; Medications; Extracorporeal Membrane Oxygenation (ECMO); Supportive Care; Other Treatment Options
Which Disruptive Trends Are Driving Change Across The Acute Respiratory Distress Syndrome (ARDS) Market?
Leading firms in the acute respiratory distress syndrome (ARDS) market are concentrating their efforts on creating novel drugs and supplements such as Aviptadil, HSP90 inhibitors, among others, to maintain their market dominance. Aviptadil, a fabricated vasoactive intestinal peptide (VIP), specifically attaches to receptors located on lung alveolar type II cells. For example, Zuventus Healthcare Ltd, a pharmaceutical manufacturer from India, introduced Aviptadil in November 2022 to address acute respiratory distress syndrome. The supplement, being a vasoactive intestinal peptide, enhances breathing and reduces mortality rates in ARDS patients. This is made possible by Aviptadil’s capabilities to shield and rejuvenate Type-2 Pneumocytes, rehabilitate Type-1 Pneumocytes, boost surfactant synthesis, and inhibit IL-6 (interleukin 6) and the tumor necrosis factor (TNF)-alpha.
Which Firms Are Making The Biggest Impact In The Acute Respiratory Distress Syndrome (ARDS) Market?
Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, ResMed Inc., Smiths Medical Inc., Dräger Safety AG & Co. KGaA., Getinge AB, Mallinckrodt PLC, Masimo Corporation, United Therapeutics Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Zuventus Healthcare Ltd., Windtree Therapeutics Inc., Faron Pharmaceuticals Oy, AcelRx Pharmaceuticals Inc.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Acute Respiratory Distress Syndrome (ARDS) Market In The Coming Years?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024. The regions covered in acute respiratory distress syndrome (ARDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13005&type=smp
Browse Through More Reports Similar to the Global Acute Respiratory Distress Syndrome (ARDS) Market 2025, By The Business Research Company
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
